This document provides information on nutrition support options for individuals with gastrointestinal dysmotility. It discusses enteral nutrition via tube feeding, including benefits, considerations for initiating and improving tolerance. Case studies demonstrate how patients with gastroparesis and mitochondrial disease were able to transition to partial or full enteral nutrition from parenteral nutrition with the help of feeding tubes and formula adjustments over time. The document also covers dietary modifications, medications, parenteral nutrition and combination therapy to support individuals with gastrointestinal motility issues.
Meal planning becomes essential thing while planning diet.People's eating habits vary enormously and we must respect dietary freedom and diversity when making recommendations and the best way to achieve is to plan meals in relation to other food for the whole day
Most of the foods we eat, provide several nutrients. So to make a wiser diet plan, it is prudent to select a combination of foods that deliver a full contingent of nutrients for good health. Our major focus should be on selecting foods that will deliver all the essential nutrients without excessive energy intake. Food choices made over years influence the body’s health, and consistently poor choices increase the risks of developing chronic diseases.
Meal planning becomes essential thing while planning diet.People's eating habits vary enormously and we must respect dietary freedom and diversity when making recommendations and the best way to achieve is to plan meals in relation to other food for the whole day
Most of the foods we eat, provide several nutrients. So to make a wiser diet plan, it is prudent to select a combination of foods that deliver a full contingent of nutrients for good health. Our major focus should be on selecting foods that will deliver all the essential nutrients without excessive energy intake. Food choices made over years influence the body’s health, and consistently poor choices increase the risks of developing chronic diseases.
Discuss essential components and purposes of nutritional assessment and nutritional screening.
Identify developmental nutritional considerations.
Identify factors influencing nutrition.
Identify anthropometric measures.
Identify risk factors and clinical signs of malnutrition.
Describe nursing interventions to promote optimal nutrition.
Plan, implement, and evaluate nursing care associated with nursing diagnoses related to nutritional problems.
A nutritionist is a person who advises others on matters of food and nutrition and their impacts on health. Some people specialize in particular areas, such as sports nutrition, public health, or animal nutrition, among other disciplines.
Discuss essential components and purposes of nutritional assessment and nutritional screening.
Identify developmental nutritional considerations.
Identify factors influencing nutrition.
Identify anthropometric measures.
Identify risk factors and clinical signs of malnutrition.
Describe nursing interventions to promote optimal nutrition.
Plan, implement, and evaluate nursing care associated with nursing diagnoses related to nutritional problems.
A nutritionist is a person who advises others on matters of food and nutrition and their impacts on health. Some people specialize in particular areas, such as sports nutrition, public health, or animal nutrition, among other disciplines.
How to Build Your Mitochondrial Medical Homemitoaction
Topics include:
The importance of a medical home for a mitochondrial disease patient.
Definition of a medical home.
How to establish a medical home.
Why a medical home is an important component of good patient advocacy.
Tips on maintaining a healthy medical home relationship.
Wees will describe theses issues primarily from a pediatric perspective, but she will give adult examples as well.
Wees is a patient advocate with Empowered Medical Advocacy. She assists parents and caregivers each week in navigating toward improved quality of life for their child and their families.
Public Relations is an industry that companies have been relying on for years but with the introduction of the internet to businesses and their publics, many companies have taken it upon themselves to handle their own PR. We at Digital by Design are about to tell you why getting an expert to take care of your Digital PR for you is the best way to go.
Roll back the pages of time for one glorious week on board the Palace on Wheels. Recapture the pomp and pageantry of a bygone era in on board this luxury train in India. Voted 4th best luxury train in the world, Palace on Wheels India will take you on a 7 days trip to wonderland which includes trip to Jaipur, Jodhpur, Udaipur, Jaisalmer, Bharatpur, Ranthambore and Bharatpur.
Dr. Mubashar A Choudry could be a sought after skilled by major hospitals and money establishments for advice on medical business development. during this capability, he advises hospitals on grow growth o of recent vas centers. He serves on the strategic coming up with committees of most hospitals within the Washington D.C. area.
Credit: www.foodinsight.org
Functional food Energy Diet (http://www.beautysane.com/UK/products.html) meet high standard ISO 9001.
* Meal substitutes for you to cook
* Around 20 flavors for varied gourmet meals
* Enriched with 23 vitamins and minerals
* Haute Digestibilité (HD), an exclusive and patented system of highly digestible products
* Each meal costs less than £3
* Made in France
* Guaranteed: no preservatives, artificial colouring, aspartame or glutamate
To order, Whatsapp +971-55-9483654
Soy protein has been found to be as effective as other high-quality proteins in supporting weight loss while increasing satiety when incorporated in a reduced calorie diet.
-What are Standards of Care and why does the Mito community need such standards?
-Review the MMS's Standards of Care for Mitochondrial Disease and how they were developed.
-Outline upcoming MMS projects.
What you should know about genetic testing for mitochondrial disordersmitoaction
Amanda Balog, CGC, Senior Genetic Counselor, Mitochondrial and Metabolic Genetics, of GeneDx discusses: "What You Should Know About Genetic Testing for Mitochondrial Disorders."
Richard Frye, MD, PhD, FAAP, FAAN, CPI, will discuss:
*The enteric (gut) microbiome has an important influence on health and disease states in humans.
* The enteric microbiome influences the human host using chemical mediators, some of which can directly affect mitochondrial function
* Short chain fatty acids produced by gut bacteria not only modulate mitochondrial function and cellular regulatory pathways, but can also be used as mitochondrial fuels.
Exercise and nutrition in Mitochondrial Diseasemitoaction
Mark Tarnopolsky, MD, PhD, FRCP,
Depts. of Pediatrics (Neuromuscular + Neurometabolic Disease) and Medicine (Cell Biology/Metabolism, Neurology and Rehabilitation), McMaster University, Hamilton, CANADA
Diagnostic Testing for Mitochondrial Diseasemitoaction
Review traditional diagnostic pathways
Discuss newer testing that has become available in recent years
Review new approaches to attempt to shorten time to diagnosis and increase precision
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
1. Presented by:
Kristen R. Roberts, PhD, RD
ThriveRx Clinical Specialist
Proprietary and Confidential of Diplomat Pharmacy Inc.
iThrive
TUBE FEEDING FOR
DYSMOTILITY CONSUMERS
2. Disclaimer
Proprietary and Confidential of Diplomat Pharmacy Inc.
Industry and Market Data
Certain information contained in this presentation concerning our industry and the markets in which we operate is based on
information from publicly available independent industry and research organizations and other third-party sources, and management
estimates. Management estimates are derived from publicly available information released by independent industry and research
analysts and third-party sources, as well as data from our internal research, and are based on assumptions made by us upon
reviewing such data and our knowledge of such industry and markets, which we believe to be reasonable. We believe the data from
these third-party sources is reliable. In addition, projections, assumptions and estimates of the future performance of the industry in
which we operate and our future performance are necessarily subject to uncertainty and risk due to a variety of factors, as discussed
in Diplomat’s reports filed with the Securities and Exchange Commission. These and other factors could cause results to differ
materially from those expressed in the estimates made by these third-party sources.
Forward-Looking Statements
This presentation contains forward-looking statements, including statements relating to pipeline reports and industry trends. The
forward-looking statements contained in this presentation are based on management's good-faith belief and reasonable judgment
based on current information, and these statements are qualified by important risks and uncertainties, many of which are beyond our
control, that could cause our actual results to differ materially from those forecasted or indicated by such forward-looking statements.
These risks are set forth in Diplomat’s most recently filed annual report on Form 10-K with, and subsequent reports filed with or
furnished to, the Securities and Exchange Commission. Diplomat assumes no obligation to publicly update such forward-looking
statements, which are made as of the date hereof or the earlier date specified herein, whether as a result of new information, future
developments or otherwise.
Medical Advice
The information contained herein may not be construed as medical advice. It is for educational purposes only. Diplomat Pharmacy
Inc. takes no responsibility for the accuracy or validity of the information contained herein, nor the claims or statements of any
manufacturer. This presentation contains proprietary information of Diplomat Pharmacy, Inc. It is intended solely for educational use.
Such proprietary information may not be used, reproduced, modified or disclosed to any other parties for any other purpose without
the express written permission of Diplomat Pharmacy Inc.
3. Nutrition Support Options for
Consumers with GI Dysmotility
Diet
• Nutrient-specific: low fiber, low fat
• Hydration: Increasing fluid intake to promote adequate hydration
• Ingestion modifications: small meals, eating more frequent meals, drinking fluids with solid food
Enteral
Nutrition (EN)
Intravenous
Hydration
• Nocturnal hydration/feeding
• Supplement specific nutrients to achieve nutritional goals
• Fluid and electrolytes administered intravenously
Parenteral
Nutrition (PN)
• Nutrition infused intravenously to meet up to 100% of nutritional needs
Proprietary and Confidential of Diplomat Pharmacy Inc.
4. Benefits of Nutrition Support
Nutrition support provides
alternatives to delivering nutrients
when eating is not possible or not
enough calories can be absorbed
Nutrition support provides
bowel rest when needed
Nutrition support can
improve surgical results
for malnourished individuals
Proprietary and Confidential of Diplomat Pharmacy Inc.
5. Initiating Nutrition Support
A plan starts with an evaluation of the GI function in order
to determine nutritional treatment options.1
Symptom evaluation and identification of trigger points in effort
to provide a nutritional plan that minimizes negative symptoms.3
2A thorough assessment of the overall nutritional status should be
completed that includes:
• Diet and weight history
• Food allergies
• Meal patterns
• Medication history
• Laboratory data
• Bowel movement patterns
Proprietary and Confidential of Diplomat Pharmacy Inc.
6. Benefits of Enteral Nutrition
Proprietary and Confidential of Diplomat Pharmacy Inc.
Maintains the health of the gastrointestinal (GI) tract
Reduces the inflammatory process
Stimulates the growth of the villi lining the small intestine
Improves GI transit time
Cost-effective
7. Enteral Nutrition: Tube feedings
Selection of EN formula depends on many factors:
Bowel anatomy
Area of the GI tract affected by the underlying condition
EN formula characteristics
Enteral formula characteristics:
Intact: intact nutrients (similar to food)
Polymeric: partially-digested nutrients
Hydrolyzed (semi-elemental and elemental): almost completely-
digested nutrients
Osmolality: concentration
Fiber content
Proprietary and Confidential of Diplomat Pharmacy Inc.
8. Delivery of Enteral Nutrition
Length of
therapy
Delivery
method
Type of
feeding tube
Proprietary and Confidential of Diplomat Pharmacy Inc.
9. Nasogastric
Through the nose to the stomach
Nasointestinal
Through the nose to the small intestine
Gastrostomy
Surgically: through the stomach wall
Endoscopically (PEG)
Jejunostomy
Surgically: through the abdominal wall to
the small intestine
Endoscopically (PEJ)
Enteral Tube Location
Proprietary and Confidential of Diplomat Pharmacy Inc.
10. The Benefits of Early Tube
Placement
• Prevention of dehydration and electrolyte
abnormalities
• Prevention of weight loss
• Prevention of malnutrition
• Improvement in fatigue
• Low risk associated with placement of an
NG or NJ tube
Proprietary and Confidential of Diplomat
Pharmacy Inc.
11
11. Determining Tolerance to EN
Proprietary and Confidential of Diplomat Pharmacy Inc.
Physical exam
Laboratory measurements
Weight changes
Number of bowel movements
Hydration status
12. Improving Tolerance to EN
• Alter medications to improve absorption and transit time
• Adjust EN formula and/or modulars
• Modify the rate of EN infusion
• Confirm that the head of the bed is at a 30° angle
• Modify the oral diet (for consumers on EN and diet)
Proprietary and Confidential of Diplomat Pharmacy Inc.
13. Diet Impacts EN Tolerance
Small, frequent meals are the easiest to tolerate.
Try ¼ to ½ c. of a given food at a time and monitor your response.
Continue to add new foods to your diet.
It is ok to re-try foods that you were unable to tolerate previously. Sometimes trying a smaller
amount at a later time will allow you to increase the variety of foods in your diet.
Chew your food well.
This is the first step in digestion and can make a
huge difference in GI tolerance.
Liquids tend to be easier to tolerate and can improve total caloric intake.
If your fullness increases as the day progresses, try switching over to liquid beverages that contain
calories (shakes, juice, milk, etc.).
Don’t lie down after a meal.
Try to sit up or walk around to help the food move throughout your GI tract.
Proprietary and Confidential of Diplomat Pharmacy Inc.
14. Avoiding Dietary Fiber
Why does fiber slow the movement of food throughout the GI tract?
Fibers can attract water and form a gel within the stomach and intestine, which slows the movement of
food throughout the GI tract.
Extensive research has demonstrated that patients on a high-fiber diet experience more abdominal pain,
discomfort, nausea and vomiting.
An overview of the fiber content within the food groups is outlined in the table below.
FOOD GROUPS FOODS TO AVOID FOODS TO CHOOSE
Grains, cereal, pasta Whole grains, brown rice, popcorn,
potatoes with the skin, high fiber cereals,
rye bread, whole wheat breads, corn bread
White bread, white rice, crackers, refined
grains, pretzels, refined cereals
Fruits, vegetables and
legumes
Skins, nuts and seeds of the plant. Avoid
uncooked fruits or vegetables. Avoid corn,
onion, lentils, peas and beans
Cooked or canned fruits and vegetables
with the skin removed, casseroles, Sweet
or white potatoes without the skin
Milk and dairy products Dairy products that are fortified with fiber. Dairy should be consumed as tolerated as
this is a naturally fiber-free food
Meats, fish, eggs and
poultry
Tough cuts of meat, processed meats (hot
dogs, sausage, cold cuts)
Baked, broiled, tender meats/fish/poultry,
tofu, ground meats, smooth peanut butter
and any style eggs
Proprietary and Confidential of Diplomat Pharmacy Inc.
15. Dietary Fat
Including liquid fats, like oils, or small amounts of fat at each meal are ways to increase fat intake while
minimizing discomfort.
Extensive research has demonstrated that patients on a high-fat diet experience more abdominal pain,
discomfort, nausea and vomiting.
An overview of the fat content within the food groups is outlined in the table below
FOOD GROUPS FOODS TO AVOID FOODS TO CHOOSE
Grains, cereal, pasta Crackers, chips, fried breading White bread, white rice, crackers, refined
grains, pretzels, refined cereals
Fruits, vegetables and
legumes
Fruits, vegetables or legumes that are fried or
cooked with excessive oil/butter
Cooked or canned fruits and vegetables with
the skin removed, sweet or white potatoes
without the skin
Milk and dairy products 2% or whole dairy products (milk, yogurt,
cheese)
If tolerated, skim or 1% dairy products (milk,
yogurt, cheese)
Meats, fish, eggs and poultry High fat beef/pork/lamb. Avoid meats with
visible fat (white-marbling)
Egg whites, skinless chicken or turkey breast,
lean pork/beef/lamb/veal, liver, fish, shrimp
and crab
Proprietary and Confidential of Diplomat Pharmacy Inc.
16. Medications for Consumers
with Dysmotility
Proprietary and Confidential of Diplomat Pharmacy Inc.
Prokinetic agents
Antiemetic drugs
Laxatives and stool softeners
Analgesics
Gastric acid suppressants
Somatostatin analogs
Antibiotics
17. Enteral Nutrition: Hydration
Fluids can be delivered through a feeding tube to help maintain hydration and/or
the health of the GI tract
Enteral hydration has been shown to be effective in reducing PN volumes in
consumers that are actively rehabilitating their intestine
Consumers that may benefit from enteral hydration include:
Consumers that can maintain their body weight, but battle with recurrent dehydration
Consumers unable to meet 100% of their hydration needs with their EN formula
PN consumers unable to tolerate EN formulas
Proprietary and Confidential of Diplomat Pharmacy Inc.
18. Parenteral Nutrition
Indications to use parenteral
nutrition in dysmotility
Unable to obtain or maintain enteral access
GI tract is non-functioning
Proprietary and Confidential of Diplomat Pharmacy Inc.
19. Combination Therapy
Using EN and PN at the same time
Uses:
To bridge a consumer that is transitioning off of PN onto EN
To feed a functioning lower GI tract when unable to maintain nutritional status without PN
Proprietary and Confidential of Diplomat Pharmacy Inc.
20. Transitioning from PN to EN
Reducing days of infusion per week
Reduce PN volume/nutrients as EN intake increases
Reduce PN infusion days (PN holiday)
Proprietary and Confidential of Diplomat Pharmacy Inc.
22. Case Study: Gastroparesis
AC is a 46-year-old male with severe gastroparesis for the last three years, who
has had gradual weight loss (84% of goal weight). AC has tried several
medications to assist with improving his gastric emptying with little improvement.
After meeting with a dietitian on several occasions, AC was placed on a liquid
diet. After two weeks of trialing a liquid diet, AC was still having significant
vomiting. Laboratory parameters suggested that AC was becoming dehydrated
with mild electrolyte abnormalities. After discussion of the plan of care with his
nutrition care team, it was determined that the dysmotility was only affecting his
stomach and the remaining sections of his GI tract were functioning. Therefore,
a trial of a nasojejunal feeding tube was recommended.
Proprietary and Confidential of Diplomat Pharmacy Inc.
23. Case Study: Gastroparesis
1-month follow-up:
AC was made NPO while his tolerance to the EN was being assessed. A
continuous nighttime infusion of a polymeric formula was initiated.
2-month follow-up:
AC was tolerating his EN at his goal rate over 12 hours at night. Since tolerance
to his EN formula was established, AC started taking sips of liquids by mouth. He
could tolerate up to ½ c. of fluids every few hours without causing increased
nausea and vomiting. It was decided to place a PEG-J feeding tube at this time.
3-month follow-up:
AC has made significant improvements in his weight and he is now 95% of his
goal weight. AC notes improvements in his chronic fatigue and is able to return
to work. He is now able to take in small bites of low-fat, low fiber foods. His
gastroenterologist is retrying several prokinetic agents at this time.
01
02
03
Proprietary and Confidential of Diplomat Pharmacy Inc.
24. Case Study: Mitochondrial Disease
MP is a 26-year-old female with MNGIE syndrome with severe GI dysmotility,
failure to thrive and loss of muscle mass. Because of the severe GI dysmotility and
failure to thrive, MP has relied on PN for the last four years. Her goal is to reduce
her PN infusion days to improve her sleeping habits and quality of life. Recently,
she visited an intestinal rehabilitation center due to her complex GI case. After a
full assessment of her GI tract, the clinical team suggested placing a nasogastric
feeding tube to see if her GI tract could tolerate EN. A polymeric formula was
selected for her first EN trial.
Proprietary and Confidential of Diplomat Pharmacy Inc.
25. Case Study: Mitochondrial Disease
1-month follow-up:
MP tolerates 25% of her EN goals due to mild diarrhea and some nausea. It was decided
to progress her feeding tube into the jejunum to see if tolerance would improve.
2-month follow-up:
MP tolerates 50% of her EN goals and her nausea was improved. She did have an
increase in her diarrhea, so a soluble fiber supplement was started through her feeding
tube. Weight gain was noted and her hydration status was excellent. MP’s PN formula was
decreased to six days per week for two weeks and then to five days per week for two
weeks. A long-term feeding tube was then placed.
3-month follow-up:
MP is able to maintain her weight on 50% EN and it was recommended to decrease her
PN to 3 days per week. She was having some difficulty maintaining her hydration status
on the days when she was not receiving PN so IVFs were sent to the home for the patient
to use as needed. Her weight continues to be monitored and slow adjustments to her EN
formula are made in effort to maximize the use of her GI tract. MP reports she is getting
better sleep now that her PN frequency is reduced.
01
02
03
Proprietary and Confidential of Diplomat Pharmacy Inc.
26. Summary
Many nutrition support options are available for consumers with
intestinal failure.
Transitioning nutrition support takes time to determine tolerance to
the nutrition support regimen.
For complex cases, working with a team of clinicians that specialize
in intestinal rehabilitation is critical.
Proprietary and Confidential of Diplomat Pharmacy Inc.
27. ThriveRx’s Mission
ThriveRx’s mission is to optimize the nutritional well-being of our
consumers through our customized approach, while maintaining the
highest standards in service and clinical care. Our mission is fulfilled by
our outstanding team, who put our consumers at the center of what we
do and work towards improving the quality of their lives.
For more information on ThriveRx’s programs and services, call us at:
888-684-7483 or email us at info@thriverx.net
Proprietary and Confidential of Diplomat Pharmacy Inc.
28. Upcoming Webinar
PEDIATRIC SBS DIET OVERVIEW
Wednesday, Dec. 9, 2015 1:00–2:00 p.m. EST
Please join us to learn more about the best diet for children with short
bowel syndrome (SBS), to maximize absorption and reduce the need for
nutrition support.
Speaker: Jill Taliaferro, RD, CNSC, ThriveRx clinical nutritionist
Proprietary and Confidential of Diplomat
Pharmacy Inc.
29
To register for this webinar, or to view recordings of
previous webinars, visit ThriveRx.net.
CONTACT US:
888.6.THRIVE
info@thriverx.net
thriverx.net
Title Slide – Option 1.
Use only one title slider per presentation.
If a patient is unable to consume adequate oral nutrition-food and/or oral nutrition supplements, a tube feeding may be recommended.
The liquid enteral formula is delivered via a small tube that enters the stomach or small intestine.
Their are several different routes through which tube feedings can be given. All of these routes allow the formula to be used as if it were a regular meal.
Nasoenteric-the feeding tube passes through the nose, down the throat and esophagus, and on into the stomach or through the stomach and into the small intestine .
Gastric-The feeding tube is surgically inserted into the stomach or small intestine through the outside of the stomach wall
New slide
New Section Slide – Misc
Use this slide when introducing topics of various subjects when other New Section slides do not fit.